Santhera Gets First Duchenne Drug OKd Under UK Early Access Scheme

 
• By Neena Brizmohun
  
DMD
Santhera's unlicensed drug can now be used to treat UK patients with Duchenne • Source: Shutterstock

More from Market Access

More from Pink Sheet